» Articles » PMID: 18488030

Genetic Variation in PSCA is Associated with Susceptibility to Diffuse-type Gastric Cancer

Abstract

Gastric cancer is classified into intestinal and diffuse types, the latter including a highly malignant form, linitis plastica. A two-stage genome-wide association study (stage 1: 85,576 SNPs on 188 cases and 752 references; stage 2: 2,753 SNPs on 749 cases and 750 controls) in Japan identified a significant association between an intronic SNP (rs2976392) in PSCA (prostate stem cell antigen) and diffuse-type gastric cancer (allele-specific odds ratio (OR) = 1.62, 95% CI = 1.38-1.89, P = 1.11 x 10(-9)). The association was far less significant in intestinal-type gastric cancer. We found that PSCA is expressed in differentiating gastric epithelial cells, has a cell-proliferation inhibition activity in vitro and is frequently silenced in gastric cancer. Substitution of the C allele with the risk allele T at a SNP in the first exon (rs2294008, which has r(2) = 0.995, D' = 0.999 with rs2976392) reduces transcriptional activity of an upstream fragment of the gene. The same risk allele was also significantly associated with diffuse-type gastric cancer in 457 cases and 390 controls in Korea (allele-specific OR = 1.90, 95% CI = 1.56-2.33, P = 8.01 x 10(-11)). The polymorphism of the PSCA gene, which is possibly involved in regulating gastric epithelial-cell proliferation, influences susceptibility to diffuse-type gastric cancer.

Citing Articles

GastricAITool: A Clinical Decision Support Tool for the Diagnosis and Prognosis of Gastric Cancer.

Aznar-Gimeno R, Garcia-Gonzalez M, Munoz-Sierra R, Carrera-Lasfuentes P, Rodrigalvarez-Chamarro M, Gonzalez-Munoz C Biomedicines. 2024; 12(9).

PMID: 39335675 PMC: 11429470. DOI: 10.3390/biomedicines12092162.


Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer.

Xu H, Han Y, Liu Z, Yin Z, Wang M, Yu C JAMA Netw Open. 2024; 7(5):e2413708.

PMID: 38809553 PMC: 11137637. DOI: 10.1001/jamanetworkopen.2024.13708.


HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.

Gnanapragasam A, Kirbizakis E, Li A, White K, Mortenson K, Cavalcante de Moura J Cancer Res. 2024; 84(14):2377-2389.

PMID: 38748784 PMC: 11247317. DOI: 10.1158/0008-5472.CAN-23-2397.


Molecular and immune characterization of Chinese early-stage non-squamous non-small cell lung cancer: a multi-omics cohort study.

Peng H, Wu X, Cui X, Liu S, Liang Y, Cai X Transl Lung Cancer Res. 2024; 13(4):763-784.

PMID: 38736486 PMC: 11082711. DOI: 10.21037/tlcr-23-800.


Significance of PSCA as a novel prognostic marker and therapeutic target for cancer.

Nayerpour Dizaj T, Doustmihan A, Sadeghzadeh Oskouei B, Akbari M, Jaymand M, Mazloomi M Cancer Cell Int. 2024; 24(1):135.

PMID: 38627732 PMC: 11020972. DOI: 10.1186/s12935-024-03320-6.